LifeMD, Inc. () Stock Analysis | Price, Returns, Financials & Key Metrics

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

1.24 M

Shareholding (Mar 2025)

FII

6.85%

Held by 40 FIIs

DII

74.33%

Held by 21 DIIs

Promoter

0.56%

How big is LifeMD, Inc.?

22-Jun-2025

As of Jun 18, LifeMD, Inc. has a market capitalization of 618.58 million and reported net sales of 234.00 million with a net profit of -10.17 million over the latest four quarters. Shareholder's funds are at -5.49 million, and total assets amount to 72.46 million.

What does LifeMD, Inc. do?

22-Jun-2025

LifeMD, Inc. is a micro-cap company in the Pharmaceuticals & Biotechnology industry, with recent net sales of $66 million and a net profit of $2 million. It has a market cap of $618.58 million and notable financial metrics, including a debt equity ratio of 6.65 and a return on equity of 436.41%.

Should I buy, sell or hold LifeMD, Inc.?

22-Jun-2025

Is LifeMD, Inc. technically bullish or bearish?

20-Sep-2025

As of September 10, 2025, LifeMD, Inc. shows a mildly bearish technical trend despite strong year-to-date and three-year performance, with mixed signals from indicators like the weekly MACD and Bollinger Bands.

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Dashboard

With a Negative Book Value, the company has a Weak Long Term Fundamental Strength

Poor long term growth as Operating profit has grown by an annual rate 11.30% of over the last 5 years
Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of -23.04

The company has declared Positive results for the last 4 consecutive quarters

Risky - Negative Operating Profits

High Institutional Holdings at 53.14%

Below par performance in long term as well as near term

Mojo Parameters

Stock DNA

Industry

Pharmaceuticals & Biotechnology

Market cap

USD 292 Million (Micro Cap)

P/E

NA (Loss Making)

Industry P/E

Dividend Yield

0.00%

Debt Equity

11.34

Return on Equity

274.64%

Price to Book

-163.95

Revenue and Profits:

Net Sales:

62 Million

(Quarterly Results - Jun 2025)

Net Profit:

-2 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

-38.85%

6 Months

-70.51%

1 Year

-39.45%

2 Years

-51.93%

3 Years

42.91%

4 Years

-6.05%

5 Years

-53.26%

LifeMD, Inc. for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

LifeMD, Inc. Forms Death Cross, Signaling Potential Bearish Trend Ahead

LifeMD, Inc. has recently encountered a technical event known as a Death Cross, indicating potential shifts in market sentiment. Current indicators show bearish trends in moving averages and MACD, alongside a decline in recent performance. Despite this, the company has outperformed the S&P 500 over the past year.

Is LifeMD, Inc. technically bullish or bearish?

As of 10 September 2025, the technical trend for LifeMD, Inc. has changed from sideways to mildly bearish. The weekly MACD is bearish, while the monthly MACD is bullish, indicating mixed signals. The Bollinger Bands and KST are both mildly bearish on a weekly and monthly basis, and Dow Theory also reflects a mildly bearish stance. Daily moving averages show a mildly bullish trend. In terms of performance, LifeMD has outperformed the S&P 500 on a year-to-date basis with a return of 29.90% compared to the S&P 500's 12.22%, and over three years, it has significantly outperformed with a return of 179.57% against the S&P 500's 70.41%. Overall, the current technical stance is mildly bearish, with key indicators such as the weekly MACD and Bollinger Bands driving this view....

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

64.36%

EBIT Growth (5y)

11.30%

EBIT to Interest (avg)

-23.04

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

6.65

Sales to Capital Employed (avg)

15.80

Tax Ratio

4.12%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

53.14%

ROCE (avg)

ROE (avg)

Valuation key factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

-248.81

EV to EBIT

-75.89

EV to EBITDA

215.33

EV to Capital Employed

-31.66

EV to Sales

2.41

PEG Ratio

Dividend Yield

ROCE (Latest)

Negative Capital Employed

ROE (Latest)

Negative BV

Technicals key factors

Indicator

Weekly

Monthly

MACD

Bearish

Mildly Bearish

RSI

No Signal

Bollinger Bands

Mildly Bearish

Bearish

Moving Averages

Bearish (Daily)

KST

Bearish

Bullish

Dow Theory

No Trend

Mildly Bearish

OBV

No Trend

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot : Mar 2025

Shareholding Compare (%holding)

Majority shareholders

Domestic Funds

Held in 28 Schemes (18.26%)

Foreign Institutions

Held by 40 Foreign Institutions (6.85%)

Strategic Entities with highest holding

Highest Public shareholder

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is -5.33% vs 2.18% in Mar 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is -184.21% vs 850.00% in Mar 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "62.20",
          "val2": "65.70",
          "chgp": "-5.33%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "1.90",
          "val2": "5.20",
          "chgp": "-63.46%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.70",
          "val2": "0.60",
          "chgp": "16.67%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-1.60",
          "val2": "1.90",
          "chgp": "-184.21%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-14.60%",
          "val2": "38.70%",
          "chgp": "-5.33%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 39.34% vs 28.15% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is -5.06% vs 60.44% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "212.50",
          "val2": "152.50",
          "chgp": "39.34%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-6.70",
          "val2": "-7.90",
          "chgp": "15.19%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "2.20",
          "val2": "2.60",
          "chgp": "-15.38%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "-0.30",
          "chgp": "100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-18.70",
          "val2": "-17.80",
          "chgp": "-5.06%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-76.00%",
          "val2": "-95.00%",
          "chgp": "1.90%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ

Jun'25

Mar'25

Change(%)

Net Sales

62.20

65.70

-5.33%

Operating Profit (PBDIT) excl Other Income

1.90

5.20

-63.46%

Interest

0.70

0.60

16.67%

Exceptional Items

0.00

Consolidate Net Profit

-1.60

1.90

-184.21%

Operating Profit Margin (Excl OI)

-14.60%

38.70%

-5.33%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Jun 2025 is -5.33% vs 2.18% in Mar 2025

Consolidated Net Profit

QoQ Growth in quarter ended Jun 2025 is -184.21% vs 850.00% in Mar 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'24

Dec'24

Dec'23

Change(%)

Net Sales

212.50

152.50

39.34%

Operating Profit (PBDIT) excl Other Income

-6.70

-7.90

15.19%

Interest

2.20

2.60

-15.38%

Exceptional Items

0.00

-0.30

100.00%

Consolidate Net Profit

-18.70

-17.80

-5.06%

Operating Profit Margin (Excl OI)

-76.00%

-95.00%

1.90%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2024 is 39.34% vs 28.15% in Dec 2023

Consolidated Net Profit

YoY Growth in year ended Dec 2024 is -5.06% vs 60.44% in Dec 2023

All Annual Results

Company CV

About LifeMD, Inc.

LifeMD, Inc.

Pharmaceuticals & Biotechnology

No Details Available.

Company Coordinates

No Company Details Available

LifeMD, Inc.

1Day

52 Week

CASH

FII

DII

Promoter

How big is LifeMD, Inc.?

Watch in Real-Time

What does LifeMD, Inc. do?

Should I buy, sell or hold LifeMD, Inc.?

Is LifeMD, Inc. technically bullish or bearish?

MarketsMojo — Loved in India, Now Global

Dashboard

With a Negative Book Value, the company has a Weak Long Term Fundamental Strength

The company has declared Positive results for the last 4 consecutive quarters

Risky - Negative Operating Profits

High Institutional Holdings at 53.14%

Below par performance in long term as well as near term

Mojo Parameters

Stock DNA

Total Returns (Price + Dividend)

Risk Adjusted Returns v/s

News

LifeMD, Inc. Forms Death Cross, Signaling Potential Bearish Trend Ahead

Is LifeMD, Inc. technically bullish or bearish?

Announcements

Corporate Actions

Quality key factors

Valuation key factors

Technicals key factors

Shareholding Snapshot : Mar 2025

Shareholding Compare (%holding)

Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ

Annual Results Snapshot (Consolidated) - Dec'24

About LifeMD, Inc.

Company Coordinates